Novavax, Inc. has entered into a license agreement with Pfizer for use of Novavax's Matrix-M® adjuvant. Under the terms of ...

Moderna’s 2028 cash breakeven guidance may not be feasible, analysts say.

By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

LOS ANGELES--(BUSINESS WIRE)--Air Lease (NYSE: AL) announced an update on aircraft investments and sales occurring in the fourth quarter of 2025. As of December 31, 2025, AL’s fleet was comprised of ...

Good afternoon, and welcome to DNB's pre-close call for the fourth quarter. Just to remind you, the reason for this call is to remind you of what we have already shared with the market and some ...

NEW YORK (PIX11) — New CDC vaccine guidelines were issued earlier today, part of the Trump administration’s effort to overhaul federal vaccine recommendations. This marks one of the most significant ...

PHILADELPHIA (WPVI) -- The United States on Monday announced it is reducing the number of vaccines recommended for children. The change takes effect immediately, lowering the Centers for Disease ...

SPARTANBURG, S.C. (WSPA) – On Monday, the Department of Health and Human Services dropped the number of vaccine recommendations for all children to 11-years-old. “The immunization schedule has been ...

Alaska state health officials continue to recommend the hepatitis B vaccine for all newborns, despite a recent, controversial change in federal guidance. State Epidemiology Chief Dr. Joe McLaughlin ...